Literature DB >> 7656248

Prognostic significance of ERBB3 overexpression in oral squamous cell carcinoma.

S Shintani1, T Funayama, Y Yoshihama, R E Alcalde, T Matsumura.   

Abstract

Immunohistochemical analysis of erbB3, as the third member of epidermal growth factor receptor gene family, was performed on 41 cases of oral squamous cell carcinoma, correlating the staining pattern with clinical outcome. High expression of erbB3 protein (ERBB3) was significantly associated with lymph node metastasis (P < 0.05), survival rate (P < 0.05) and mode of invasion (P < 0.01) in this series. These results demonstrated that ERBB3 expression may be helpful in identifying those oral squamous cell carcinomas with higher malignant potential.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7656248     DOI: 10.1016/0304-3835(95)03866-u

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  15 in total

Review 1.  Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma.

Authors:  Giovana R Thomas; Hari Nadiminti; Jacinto Regalado
Journal:  Int J Exp Pathol       Date:  2005-12       Impact factor: 1.925

2.  Identification of biomarkers in human head and neck tumor cell lines that predict for in vitro sensitivity to gefitinib.

Authors:  D Mark Hickinson; Gayle B Marshall; Garry J Beran; Marileila Varella-Garcia; Elizabeth A Mills; Marie C South; Andrew M Cassidy; Kerry L Acheson; Gael McWalter; Rose M McCormack; Paul A Bunn; Tim French; Alex Graham; Brian R Holloway; Fred R Hirsch; Georgina Speake
Journal:  Clin Transl Sci       Date:  2009-06       Impact factor: 4.689

3.  ErbB3 upregulation by the HNSCC 3D microenvironment modulates cell survival and growth.

Authors:  J O Humtsoe; E Pham; R J Louie; D A Chan; R H Kramer
Journal:  Oncogene       Date:  2015-06-15       Impact factor: 9.867

4.  Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands.

Authors:  P O-charoenrat; P Rhys-Evans; W J Court; G M Box; S A Eccles
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

Review 5.  The role of epidermal growth factor receptor in head and neck squamous cell carcinoma.

Authors:  Rebecca G Pomerantz; Jennifer Rubin Grandis
Journal:  Curr Oncol Rep       Date:  2003-03       Impact factor: 5.075

Review 6.  Emerging therapies in gastrointestinal cancers.

Authors:  Jyoti Nautiyal; Arun K Rishi; Adhip P N Majumdar
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742

Review 7.  The ERBB3 receptor in cancer and cancer gene therapy.

Authors:  G Sithanandam; L M Anderson
Journal:  Cancer Gene Ther       Date:  2008-04-11       Impact factor: 5.987

8.  Enhancement of erbB2 and erbB3 expression during oral oncogenesis in diabetic rats.

Authors:  Eleftherios Vairaktaris; Lambros Goutzanis; Stavros Vassiliou; Sofia Spyridonidou; Emeka Nkenke; Georgios Papageorgiou; Pashalis Strantzias; Andreas Lazaris; Christos Yapijakis; Efstratios Patsouris
Journal:  J Cancer Res Clin Oncol       Date:  2007-08-18       Impact factor: 4.553

Review 9.  ErbB receptors in the biology and pathology of the aerodigestive tract.

Authors:  Sarah Morgan; Jennifer R Grandis
Journal:  Exp Cell Res       Date:  2008-08-23       Impact factor: 3.905

10.  Bone microenvironment and androgen status modulate subcellular localization of ErbB3 in prostate cancer cells.

Authors:  Chien-Jui Cheng; Xiang-cang Ye; Funda Vakar-Lopez; Jeri Kim; Shi-Ming Tu; Dung-Tsa Chen; Nora M Navone; Li-Yuan Yu-Lee; Sue-Hwa Lin; Mickey C-T Hu
Journal:  Mol Cancer Res       Date:  2007-07       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.